Key result
Hyperpotassemia increased the ventricular excitability threshold (from <1 V to >6 V in one patient), leading to unresponsiveness to implanted pacemakers.
Why the study?
Does hyperpotassemia increase the ventricular excitability threshold in patients with implanted pacemakers?
Case Report (n=2)
Does hyperpotassemia increase the ventricular excitability threshold in patients with implanted pacemakers?
Answers are grounded in this paper and cite their sources.
Hyperpotassemia increases the ventricular excitability threshold, which can lead to failure of implanted pacemakers to capture the myocardium.
Hyperpotassemia increases excitability threshold of the ventricular myocardium and may be responsible for the failure of the implanted pacemakers. The following observations support this hypothesis: (1) A patient with hyperpotassemia became unresponsive to stimulation by a nondefective, implanted pacemaker. (2) In another patient with a transvenous pacemaker, excitability threshold increased from less than one volt (v) to more than six v when plasma potassium concentration was raised from 4.0 to 7.1 mEq/liter. (3) In dogs, ventricular excitability threshold increased with increasing potassium concentration. These observations suggest that in patients with implanted pacemakers hyperpotassemia must be prevented and promptly treated.
No takes yet. Share an insight, caveat, or question.
Borys Surawicz (1965) conducted a case report in Hyperpotassemia with implanted pacemakers (n=2). Hyperpotassemia vs. Normokalemia was evaluated on Ventricular excitability threshold. Hyperpotassemia increased the ventricular excitability threshold (from <1 V to >6 V in one patient), leading to unresponsiveness to implanted pacemakers.
Synapse has enriched 10 related papers. Consider them for comparative context: